Author

Eugeni Domenech Morral

CLINICAL AND PHARMACOKINETIC IMPACT OF METHYLPREDNISOLONE PREMEDICATION WITHDRAWAL IN INFLAMMATORY BOWEL DISEASE PATIENTS ON MAINTENANCE THERAPY WITH INFLIXIMAB
CLINICAL AND PHARMACOKINETIC IMPACT OF METHYLPREDNISOLONE PREMEDICATION WITHDRAWAL IN INFLAMMATORY BOWEL DISEASE PATIENTS ON MAINTENANCE THERAPY WITH INFLIXIMAB

Eugeni Domenech Morral  et al.

LOW ADHESION TO LATENT TUBERCULOSIS (TB) SCREENING RECOMMENDATIONS IN INFLAMMATORY BOWEL DISEASE (IBD) PATIENTS: RESULTS OF THE INFEII REGISTRY OF GETECCU
LOW ADHESION TO LATENT TUBERCULOSIS (TB) SCREENING RECOMMENDATIONS IN INFLAMMATORY BOWEL DISEASE (IBD) PATIENTS: RESULTS OF THE INFEII REGISTRY OF GETECCU

Eugeni Domenech Morral  et al.

IMMUNOSUPPRESSIVE TREATMENT IS NOT A RISK FACTOR TO DEVELOP A WORSE SARS-COV-2 INFECTION IN ELDERLY IBD PATIENTS. AN OBSERVATIONAL, DESCRIPTIVE, COHORT STUDY
IMMUNOSUPPRESSIVE TREATMENT IS NOT A RISK FACTOR TO DEVELOP A WORSE SARS-COV-2 INFECTION IN ELDERLY IBD PATIENTS. AN OBSERVATIONAL, DESCRIPTIVE, COHORT STUDY

Eugeni Domenech Morral  et al.

CORRELATION BETWEEN MICROBIAL MARKERS AND FAECAL CALPROTECTIN IN IBD PATIENTS
CORRELATION BETWEEN MICROBIAL MARKERS AND FAECAL CALPROTECTIN IN IBD PATIENTS

Eugeni Domenech Morral  et al.

USE OF MYCOPHENOLATE MOFETIL IN INFLAMMATORY BOWEL DISEASE: RESULTS FROM THE ENEIDA REGISTRY
USE OF MYCOPHENOLATE MOFETIL IN INFLAMMATORY BOWEL DISEASE: RESULTS FROM THE ENEIDA REGISTRY

Eugeni Domenech Morral  et al.

COMPARISON OF THE EFFICACY OF A SECOND INTRAVENOUS OR SUBCUTANEOUS ANTI-TNF IN THE TREATMENT OF ULCERATIVE COLITIS. REAL-WORLD DATA FROM THE ENEIDA REGISTRY
COMPARISON OF THE EFFICACY OF A SECOND INTRAVENOUS OR SUBCUTANEOUS ANTI-TNF IN THE TREATMENT OF ULCERATIVE COLITIS. REAL-WORLD DATA FROM THE ENEIDA REGISTRY

Eugeni Domenech Morral  et al.

EFFECT OF COVID RELATED RESTRICTIONS ON IRRITABLE BOWEL SYNDROME PSYCHOLOGICAL WELL-BEING. A COMPARATIVE STUDY WITH ULCERATIVE COLITIS
EFFECT OF COVID RELATED RESTRICTIONS ON IRRITABLE BOWEL SYNDROME PSYCHOLOGICAL WELL-BEING. A COMPARATIVE STUDY WITH ULCERATIVE COLITIS

Eugeni Domenech Morral  et al.

DEFINITION OF A MICROBIAL SIGNATURE AS A PREDICTOR OF POST-SURGICAL RECURRENCE IN PATIENTS WITH CROHN'S DISEASE
DEFINITION OF A MICROBIAL SIGNATURE AS A PREDICTOR OF POST-SURGICAL RECURRENCE IN PATIENTS WITH CROHN'S DISEASE

Eugeni Domenech Morral  et al.

MANAGEMENT AND OUTCOME OF POSTOPERATIVE CROHN’S DISEASE IN THE ELDERLY AS COMPARED TO YOUNG ADULTS: DATA FROM ENEIDA REGISTRY
MANAGEMENT AND OUTCOME OF POSTOPERATIVE CROHN’S DISEASE IN THE ELDERLY AS COMPARED TO YOUNG ADULTS: DATA FROM ENEIDA REGISTRY

Eugeni Domenech Morral  et al.

LONG-TERM OUTCOMES OF BIOLOGIC THERAPY IN CROHN’S DISEASE COMPLICATED WITH INTERNAL FISTULIZING DISEASE: BIOSCOPE STUDY FROM GETECCU
LONG-TERM OUTCOMES OF BIOLOGIC THERAPY IN CROHN’S DISEASE COMPLICATED WITH INTERNAL FISTULIZING DISEASE: BIOSCOPE STUDY FROM GETECCU

Eugeni Domenech Morral  et al.

LONG-TERM OUTCOMES OF ENTEROCUTANEOUS FISTULA COMPLICATING CROHN’S DISEASE: ECUFIT STUDY FROM GETECCU
LONG-TERM OUTCOMES OF ENTEROCUTANEOUS FISTULA COMPLICATING CROHN’S DISEASE: ECUFIT STUDY FROM GETECCU

Eugeni Domenech Morral  et al.

COMORBIDITIES AND EPIDEMIOLOGICAL RISK FACTOR BUT NOT IMMUNOSUPPRESSIVE THERAPIES INCREASE THE RISK OF COVID-19 IN INFLAMMATORY BOWEL DISEASE (IBD): AN ENEIDA-BASED, CASE-CONTROL STUDY
COMORBIDITIES AND EPIDEMIOLOGICAL RISK FACTOR BUT NOT IMMUNOSUPPRESSIVE THERAPIES INCREASE THE RISK OF COVID-19 IN INFLAMMATORY BOWEL DISEASE (IBD): AN ENEIDA-BASED, CASE-CONTROL STUDY

Eugeni Domenech Morral  et al.

INFLAMMATORY BOWEL DISEASE IN IMMIGRANTS TO SPAIN: RESULTS OF THE EIIMIGRA STUDY FROM GETECCU (ENEIDA REGISTRY)
INFLAMMATORY BOWEL DISEASE IN IMMIGRANTS TO SPAIN: RESULTS OF THE EIIMIGRA STUDY FROM GETECCU (ENEIDA REGISTRY)

Eugeni Domenech Morral  et al.

INFLAMMATORY BOWEL DISEASE (IBD) AND IMMUNOSUPPRESSION DO NOT WORSEN THE PROGNOSIS OF COVID-19. RESULTS FROM THE ENEIDA PROJECT OF GETECCU
INFLAMMATORY BOWEL DISEASE (IBD) AND IMMUNOSUPPRESSION DO NOT WORSEN THE PROGNOSIS OF COVID-19. RESULTS FROM THE ENEIDA PROJECT OF GETECCU

Eugeni Domenech Morral  et al.

Item 1 - 14 / 14
1